SHUKRAPHAR Q2 FY27: revenue up 649.2% to ₹44 Cr, net profit up 429.2% to ₹13 Cr
Results · Finvezto · 5 Nov 2026 · SHUKRAPHAR (SHUKRAPHAR)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 44 | +88.1% | +649.2% |
| Operating profit | 19 | -2.1% | +4775.0% |
| Net profit | 13 | -2.3% | +429.2% |
| Operating margin | 42.3% | -39.0 pp | +35.8 pp |
| Net margin | 28.7% | -26.6 pp | -11.9 pp |
Key points
- For Q2 FY27, Shukra Medtech Limited reported standalone revenue from operations of Rs 44.20 crore, up 652% from Rs 5.88 crore in Q2 FY26, with EBITDA turning positive to Rs 22.01 crore and net profit rising 573% to Rs 16.01 crore. NSE filing
- The growth was driven primarily by overseas customer expansion in exports, while the MedTech arm contributed segment revenue of Rs 12.51 crore. NSE filing
- Revenue was ₹44 Cr, up 649.2% on a year earlier and up 88.1% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 69.3%, 6.3%, 81.3%, 42.3%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 20, -2, 13, 13.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.